Researchers in Dr. Laura Attardi's lab have created a knock-in mouse strain which generates a form of p53 that is not subject to degradation by the proteasome.
Stanford investigators have found a mechanistic difference between p53's ability to induce responses to acute DNA damage (either apoptosis or cell cycle arrest) versus oncogenic stimuli.